These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33544218)

  • 1. Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson's Disease.
    Schaeffer E; Vaterrodt T; Zaunbrecher L; Liepelt-Scarfone I; Emmert K; Roeben B; Elshehabi M; Hansen C; Becker S; Nussbaum S; Busch JH; Synofzik M; Berg D; Maetzler W
    J Neurol; 2021 Jul; 268(7):2506-2514. PubMed ID: 33544218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nocturnal symptoms in advanced Parkinson's disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations.
    Xiang W; Sun YQ; Teoh HC
    Drug Des Devel Ther; 2018; 12():2017-2024. PubMed ID: 30013321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease.
    Del Pino R; Murueta-Goyena A; Ayala U; Acera M; Fernández M; Tijero B; Carmona M; Fernández T; Gabilondo I; Gómez-Esteban JC
    PLoS One; 2021; 16(12):e0259935. PubMed ID: 34851977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of nocturnal hypokinesia and sleep quality in Parkinson's disease.
    Xue F; Wang FY; Mao CJ; Guo SP; Chen J; Li J; Wang QJ; Bei HZ; Yu Q; Liu CF
    J Clin Neurosci; 2018 Aug; 54():96-101. PubMed ID: 29908717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
    Zibetti M; Rizzone M; Merola A; Angrisano S; Rizzi L; Montanaro E; Cicolin A; Lopiano L
    Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time for a strategy in night-time dopaminergic therapy? An objective sensor-based analysis of nocturnal hypokinesia and sleeping positions in Parkinson's disease.
    Sringean J; Anan C; Thanawattano C; Bhidayasiri R
    J Neurol Sci; 2017 Feb; 373():244-248. PubMed ID: 28131197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease.
    Chahine LM; Daley J; Horn S; Duda JE; Colcher A; Hurtig H; Cantor C; Dahodwala N
    Parkinsonism Relat Disord; 2013 Oct; 19(10):859-63. PubMed ID: 23751512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative influence of L-dopa on subjectively assessed sleep but not on nocturnal polysomnography in Parkinson's disease.
    Antczak JM; Rakowicz MJ; Banach M; Derejko M; Sienkiewicz J; Zalewska U; Więcławska M; Jakubczyk T; Jernajczyk W
    Pharmacol Rep; 2013; 65(3):614-23. PubMed ID: 23950583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson's disease patients.
    Ledda C; Romagnolo A; Covolo A; Imbalzano G; Montanaro E; Rizzone MG; Artusi CA; Lopiano L; Zibetti M
    J Neurol; 2024 Jun; 271(6):3625-3630. PubMed ID: 38607429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease.
    Ricciardi L; Bove F; Espay KJ; Lena F; Modugno N; Poon YY; Krikorian R; Espay AJ; Fasano A
    Mov Disord; 2016 Apr; 31(4):597-8. PubMed ID: 26946221
    [No Abstract]   [Full Text] [Related]  

  • 11. Sleep disorders in Parkinson's disease.
    Stocchi F; Barbato L; Nordera G; Berardelli A; Ruggieri S
    J Neurol; 1998 May; 245 Suppl 1():S15-8. PubMed ID: 9617717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring.
    van Hilten B; Hoff JI; Middelkoop HA; van der Velde EA; Kerkhof GA; Wauquier A; Kamphuisen HA; Roos RA
    Arch Neurol; 1994 Sep; 51(9):922-8. PubMed ID: 8080393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
    Taguchi S; Koide H; Oiwa H; Hayashi M; Ogawa K; Ito C; Nakashima K; Yuasa T; Yasumoto A; Ando H; Fujikake A; Fukuoka T; Tokui K; Izumi M; Tsunoda Y; Kawagashira Y; Okada Y; Niwa JI; Doyu M
    PLoS One; 2021; 16(7):e0255274. PubMed ID: 34320022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study.
    Romigi A; Stanzione P; Marciani MG; Izzi F; Placidi F; Cervellino A; Giacomini P; Brusa L; Grossi K; Pierantozzi M
    J Neural Transm (Vienna); 2006 Dec; 113(12):1909-13. PubMed ID: 16736238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How well do Parkinson's disease patients turn in bed? Quantitative analysis of nocturnal hypokinesia using multisite wearable inertial sensors.
    Sringean J; Taechalertpaisarn P; Thanawattano C; Bhidayasiri R
    Parkinsonism Relat Disord; 2016 Feb; 23():10-6. PubMed ID: 26683743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between severity of motor function and nonmotor symptoms in Parkinson's disease: a post hoc analysis of the RECOVER Study.
    Swick TJ; Friedman JH; Chaudhuri KR; Surmann E; Boroojerdi B; Moran K; Ghys L; Trenkwalder C
    Eur Neurol; 2014; 71(3-4):140-7. PubMed ID: 24457253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The factors impact on the urgent daytime sleepiness degree in the Parkinson's disease].
    Nodel MR; Shevtsova KV; Kovrov GV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):102-108. PubMed ID: 36279235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep disturbances in drug naïve Parkinson's disease (PD) patients and effect of levodopa on sleep.
    Ferreira T; Prabhakar S; Kharbanda PS
    Ann Indian Acad Neurol; 2014 Oct; 17(4):416-9. PubMed ID: 25506163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson's disease.
    Tall P; Qamar MA; Batzu L; Leta V; Falup-Pecurariu C; Ray Chaudhuri K
    J Neural Transm (Vienna); 2023 Nov; 130(11):1443-1449. PubMed ID: 37126118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications.
    Bay AA; Hart AR; Michael Caudle W; Corcos DM; Hackney ME
    J Neurol Sci; 2019 Jan; 396():262-265. PubMed ID: 30537631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.